284 related articles for article (PubMed ID: 3328164)
21. Topical Minoxidil: Systematic Review and Meta-Analysis of Its Efficacy in Androgenetic Alopecia.
Gupta AK; Charrette A
Skinmed; 2015; 13(3):185-9. PubMed ID: 26380504
[TBL] [Abstract][Full Text] [Related]
22. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.
Roberts J; Desai N; McCoy J; Goren A
Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771
[TBL] [Abstract][Full Text] [Related]
23. Androgenetic alopecia: an evidence-based treatment update.
Varothai S; Bergfeld WF
Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
[TBL] [Abstract][Full Text] [Related]
24. Androgenetic alopecia treated with topical minoxidil.
De Villez RL
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):669-72. PubMed ID: 3549800
[TBL] [Abstract][Full Text] [Related]
25. Doppler laser imaging predicts response to topical minoxidil in the treatment of female pattern hair loss.
McCoy J; Kovacevic M; Situm M; Stanimirovic A; Bolanca Z; Goren A
J Biol Regul Homeost Agents; 2016; 30(1):131-4. PubMed ID: 27049083
[TBL] [Abstract][Full Text] [Related]
26. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
[TBL] [Abstract][Full Text] [Related]
27. Dose-response study of topical minoxidil in male pattern alopecia.
Shupack JL; Kassimir JJ; Thirumoorthy T; Reed ML; Jondreau L
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):673-6. PubMed ID: 3549801
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of oral minoxidil in the treatment of alopecia areata.
Fiedler-Weiss VC; Rumsfield J; Buys CM; West DP; Wendrow A
Arch Dermatol; 1987 Nov; 123(11):1488-90. PubMed ID: 3674909
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of topical minoxidil in the management of androgenetic alopecia.
Rietschel RL; Duncan SH
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):677-85. PubMed ID: 3549802
[TBL] [Abstract][Full Text] [Related]
30. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
[TBL] [Abstract][Full Text] [Related]
31. A pilot split-scalp study of combined fractional radiofrequency microneedling and 5% topical minoxidil in treating male pattern hair loss.
Yu AJ; Luo YJ; Xu XG; Bao LL; Tian T; Li ZX; Dong YX; Li YH
Clin Exp Dermatol; 2018 Oct; 43(7):775-781. PubMed ID: 29952106
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of 2% topical minoxidil in the management of male pattern baldness in Chinese.
Kuan YZ; Chen SY; Chen MJ; Wang CN; Chan HL
Changgeng Yi Xue Za Zhi; 1990 Jun; 13(2):96-103. PubMed ID: 2224611
[TBL] [Abstract][Full Text] [Related]
33. Topical minoxidil therapy for androgenetic alopecia.
Epstein E
Arch Dermatol; 1988 Mar; 124(3):322-3. PubMed ID: 3345081
[No Abstract] [Full Text] [Related]
34. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
DeVillez RL; Jacobs JP; Szpunar CA; Warner ML
Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407
[TBL] [Abstract][Full Text] [Related]
35. Topical minoxidil dose-response effect in alopecia areata.
Fiedler-Weiss VC; West DP; Buys CM; Rumsfield JA
Arch Dermatol; 1986 Feb; 122(2):180-2. PubMed ID: 3947124
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of androgenic alopecia with topical minoxidil].
Brenner S; Tamir A
Harefuah; 1991 Nov; 121(9):297-302. PubMed ID: 1800277
[TBL] [Abstract][Full Text] [Related]
37. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
Gassmueller J; Hoffmann R; Webster A
Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
[TBL] [Abstract][Full Text] [Related]
38. A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study.
Abdel-Raouf H; Aly UF; Medhat W; Ahmed SS; Abdel-Aziz RTA
Dermatol Ther; 2021 Jan; 34(1):e14678. PubMed ID: 33320406
[TBL] [Abstract][Full Text] [Related]
39. Minoxidil: a comprehensive review.
Gupta AK; Talukder M; Venkataraman M; Bamimore MA
J Dermatolog Treat; 2022 Jun; 33(4):1896-1906. PubMed ID: 34159872
[TBL] [Abstract][Full Text] [Related]
40. Three percent topical minoxidil therapy for female androgenetic alopecia.
Hordinsky MK; Shank J
Clin Dermatol; 1988; 6(4):213-7. PubMed ID: 3214822
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
